Spyglass Pharma

Spyglass develops a drug delivery platform for glaucoma patients. An implanted lens slowly releases medication, eliminating the need for eye drops.
Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2026
Stage of Initial Investment
Series C
Initial Investment Year
2023